Labeler
Zydus Lifesciences Limited NDC Codes
Zydus Lifesciences Limited lists 661 finished drug products in the FDA NDC Directory under NDC labeler codes 65841, 70771.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Selexipag, Isotretinoin, dasatinib, brivaracetam, tofacitinib, Diltiazem hydrochloride, Eltrombopag, Ascorbic acid, Verapamil hydrochloride, gabapentin, oxcarbazepine, sacubitril and valsartan, minocycline hydrochloride, Zituvimet XR, Sitagliptin and Metformin Hydrochloride
- Active ingredients
- Selexipag, Isotretinoin, Dasatinib, Sitagliptin, Metformin hydrochloride, Brivaracetam, Valsartan, Tofacitinib citrate, Diltiazem hydrochloride, Eltrombopag olamine, Ascorbic acid, Verapamil hydrochloride
- NDC labeler codes
- 65841, 70771
- Strengths (from the 100 most recently listed products)
- Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1; Ascorbic acid 500 mg/mL; Metformin hydrochloride 500 mg/1; Sitagliptin 100 mg/1; Tretinoin .25 mg/g; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Tofacitinib citrate 10 mg/1; Fluorescein sodium 100 mg/mL; Fluorescein sodium 250 mg/mL; Diltiazem hydrochloride 30 mg/1; Diltiazem hydrochloride 60 mg/1; Diltiazem hydrochloride 90 mg/1; Diltiazem hydrochloride 120 mg/1; Verapamil hydrochloride 120 mg/1; Verapamil hydrochloride 180 mg/1; Verapamil hydrochloride 240 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Tablet, Film coated, Extended release, Injection, Kit, Injection, Solution, Tablet, Extended release, Cream, Capsule, Extended release, Tablet, For suspension, Gel, Powder, For solution, Shampoo, Injection, Powder, Lyophilized, For solution, Capsule, Coated pellets, Patch, Extended release
- Routes
- Oral, Intravenous, Topical, Intramuscular, Subcutaneous, Transdermal
- Drug classes (FDA established)
- Prostacyclin Receptor Agonist, Retinoid, Calcium Channel Blocker, Serotonin Reuptake Inhibitor, Kinase Inhibitor, Biguanide, Dipeptidyl Peptidase 4 Inhibitor, Angiotensin 2 Receptor Blocker, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Anti-epileptic Agent, Vitamin C, Neprilysin Inhibitor, Tetracycline-class Drug, Diagnostic Dye, Sodium-Glucose Cotransporter 2 Inhibitor, Sulfone, Serotonin-4 Receptor Agonist, Amide Local Anesthetic, Corticosteroid, Cholinergic Receptor Agonist, Calcitonin, Oxidation-Reduction Agent, Antiparasitic, Pediculicide, Endothelin Receptor Antagonist, Nitroimidazole Antimicrobial, Xanthine Oxidase Inhibitor, Histamine-2 Receptor Antagonist, Nonsteroidal Anti-inflammatory Drug, Azole Antifungal, Antiarrhythmic, l-Thyroxine, Anticholinergic
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 173 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| gabapentin | Gabapentin 750 mg/1 | TabletOral | 70771-1917 | 70771-1917-0170771-1917-06 | — |
| gabapentin | Gabapentin 900 mg/1 | TabletOral | 70771-1918 | 70771-1918-0170771-1918-06 | — |
| oxcarbazepine | Oxcarbazepine 150 mg/1 | TabletOral | 70771-1842 | 70771-1842-0170771-1842-0470771-1842-05 | — |
| oxcarbazepine | Oxcarbazepine 300 mg/1 | TabletOral | 70771-1843 | 70771-1843-0070771-1843-0170771-1843-04+1 more | — |
| oxcarbazepine | Oxcarbazepine 600 mg/1 | TabletOral | 70771-1844 | 70771-1844-0170771-1844-0470771-1844-05 | — |
| sacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | TabletOral | 70771-1921 | 70771-1921-0470771-1921-0670771-1921-08 | — |
| sacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | TabletOral | 70771-1922 | 70771-1922-0470771-1922-0670771-1922-08 | — |
| sacubitril and valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | TabletOral | 70771-1923 | 70771-1923-0470771-1923-0670771-1923-08 | — |
| Allopurinol | Allopurinol 200 mg/1 | TabletOral | 70771-1907 | 70771-1907-0070771-1907-09 | — |
| minocycline hydrochloride | Minocycline hydrochloride 55 mg/1 | Tablet, Extended releaseOral | 70771-1153 | 70771-1153-0070771-1153-0170771-1153-03+3 more | — |
| minocycline hydrochloride | Minocycline hydrochloride 65 mg/1 | Tablet, Extended releaseOral | 70771-1154 | 70771-1154-0070771-1154-0170771-1154-03+3 more | — |
| minocycline hydrochloride | Minocycline hydrochloride 115 mg/1 | Tablet, Extended releaseOral | 70771-1158 | 70771-1158-0070771-1158-0170771-1158-03+3 more | — |
| Isotretinoin | Isotretinoin 10 mg/1 | CapsuleOral | 70771-1662 | 70771-1662-08 | — |
| Isotretinoin | Isotretinoin 20 mg/1 | CapsuleOral | 70771-1663 | 70771-1663-08 | — |
| Isotretinoin | Isotretinoin 25 mg/1 | CapsuleOral | 70771-1664 | 70771-1664-08 | — |
| Isotretinoin | Isotretinoin 30 mg/1 | CapsuleOral | 70771-1665 | 70771-1665-08 | — |
| Isotretinoin | Isotretinoin 35 mg/1 | CapsuleOral | 70771-1666 | 70771-1666-08 | — |
| Isotretinoin | Isotretinoin 40 mg/1 | CapsuleOral | 70771-1667 | 70771-1667-08 | — |
| Ibuprofen and Famotidine | Ibuprofen 800 mg/1; Famotidine 26.6 mg/1 | TabletOral | 70771-1924 | 70771-1924-09 | — |
| vigabatrin | Vigabatrin 500 mg/10mL | Powder, For solutionOral | 70771-1742 | 70771-1742-08 | — |
| Methenamine hippurate | Methenamine hippurate 1 g/1 | TabletOral | 70771-1919 | 70771-1919-01 | — |
| Ketoconazole | Ketoconazole 20 mg/mL | ShampooTopical | 70771-1874 | 70771-1874-07 | — |
| dasatinib | Dasatinib 20 mg/1 | TabletOral | 70771-1901 | 70771-1901-06 | — |
| dasatinib | Dasatinib 50 mg/1 | TabletOral | 70771-1902 | 70771-1902-06 | — |
| dasatinib | Dasatinib 70 mg/1 | TabletOral | 70771-1903 | 70771-1903-06 | — |
| dasatinib | Dasatinib 80 mg/1 | TabletOral | 70771-1904 | 70771-1904-03 | — |
| dasatinib | Dasatinib 100 mg/1 | TabletOral | 70771-1905 | 70771-1905-03 | — |
| dasatinib | Dasatinib 140 mg/1 | TabletOral | 70771-1906 | 70771-1906-03 | — |
| Selexipag | Selexipag 200 ug/1 | Tablet, Film coatedOral | 70771-1793 | 70771-1793-0670771-1793-08 | — |
| Selexipag | Selexipag 400 ug/1 | Tablet, Film coatedOral | 70771-1794 | 70771-1794-06 | — |
| Selexipag | Selexipag 600 ug/1 | Tablet, Film coatedOral | 70771-1795 | 70771-1795-06 | — |
| Selexipag | Selexipag 800 ug/1 | Tablet, Film coatedOral | 70771-1796 | 70771-1796-06 | — |
| Selexipag | Selexipag 1000 ug/1 | Tablet, Film coatedOral | 70771-1797 | 70771-1797-06 | — |
| Selexipag | Selexipag 1200 ug/1 | Tablet, Film coatedOral | 70771-1798 | 70771-1798-06 | — |
| Selexipag | Selexipag 1400 ug/1 | Tablet, Film coatedOral | 70771-1799 | 70771-1799-06 | — |
| Selexipag | Selexipag 1600 ug/1 | Tablet, Film coatedOral | 70771-1800 | 70771-1800-06 | — |
| Selexipag TITRATION PACKselexipag | — | Kit | 70771-1801 | 70771-1801-07 | — |
| Lidocaine and prilocaine | Lidocaine 25 mg/g; Prilocaine 25 mg/g | CreamTopical | 70771-1872 | 70771-1872-0270771-1872-08 | — |
| Fludrocortisone acetate | Fludrocortisone acetate .1 mg/1 | TabletOral | 70771-1893 | 70771-1893-0170771-1893-05 | — |
| Levothyroxine Sodium | Levothyroxine sodium anhydrous 100 ug/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70771-1818 | 70771-1818-01 | — |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 70771-1879 | 70771-1879-06 | — |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 70771-1880 | 70771-1880-06 | — |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 100 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 70771-1881 | 70771-1881-03 | — |
| Sitagliptin and Metformin Hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 70771-1886 | 70771-1886-06 | — |
| Sitagliptin and Metformin Hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 70771-1887 | 70771-1887-06 | — |
| Sitagliptin and Metformin Hydrochloride | Sitagliptin 100 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 70771-1888 | 70771-1888-03 | — |
| topiramate | Topiramate 50 mg/1 | Capsule, Coated pelletsOral | 65841-846 | 65841-0846-14 | — |
| Scopolamine | Scopolamine 1 mg/3d | Patch, Extended releaseTransdermal | 70771-1787 | 70771-1787-0270771-1787-0470771-1787-07 | — |
| Valsartan | Valsartan 40 mg/1 | Tablet, Film coatedOral | 70771-1882 | 70771-1882-03 | — |
| Valsartan | Valsartan 80 mg/1 | Tablet, Film coatedOral | 70771-1883 | 70771-1883-09 | — |
Zydus Lifesciences Limited: common questions
- What is Zydus Lifesciences Limited's NDC labeler code?
- 65841, 70771. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Lifesciences Limited?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.